Do you have a question about our COVID-19 vaccine candidate?
A member of Medicago’s Board of Directors since 2017 and Chairman of the Board since 2018, Takashi Nagao was appointed President and CEO of Medicago in December 2020.
A recognized leader in health and pharmaceuticals, Takashi has always relied on his knowledge of drug development and marketing, business development and finance to support business growth.
He supported the deployment of Mitsubishi Tanabe in the United States in leadership positions at MTPC Holdings Canada, Mitsubishi Tanabe Pharma Development America, MP Healthcare Venture Management and Mitsubishi Tanabe Pharma America.
These experiences included overseeing the start-up of venture capital investment, translational research, clinical development, medical affairs, regulatory affairs, drug safety, supply management, quality control, commercialization, market management, legal and compliance, and human resources.